Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30471% above fair value
$24.60−1.44 (-5.53%)
Close on Nov 13, 2026Market cap $3.82BP/E –Yield –
Zai Lab total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zai Lab's total debt was $252.37M at Sep 30, 2026. For fiscal 2025 it was $204.53M, up 55.3% from the year before. The highest annual figure on record is $204.53M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $204.53M | +55.3% |
| FY2024 | Dec 31, 2024 | $131.71M | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $6.45M | +77.1% |
| FY2018 | Dec 31, 2018 | $3.64M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $252.37M | +24.3% |
| Q2 FY2026 | Jun 30, 2026 | $238.10M | +36.4% |
| Q1 FY2026 | Mar 31, 2026 | $213.82M | +23.3% |
| Q4 FY2025 | Dec 31, 2025 | $204.53M | +55.3% |
| Q3 FY2025 | Sep 30, 2025 | $203.03M | +79.7% |
| Q2 FY2025 | Jun 30, 2025 | $174.51M | +148.2% |
| Q1 FY2025 | Mar 31, 2025 | $173.41M | +259.2% |
| Q4 FY2024 | Dec 31, 2024 | $131.71M | – |
| Q3 FY2024 | Sep 30, 2024 | $112.99M | +2566.2% |
| Q2 FY2024 | Jun 30, 2024 | $70.30M | +989.9% |
| Q1 FY2024 | Mar 31, 2024 | $48.27M | +658.7% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $4.24M | – |
| Q4 FY2019 | Dec 31, 2019 | $6.45M | – |
| Q3 FY2019 | Sep 30, 2019 | $6.36M | – |
| Q4 FY2018 | Dec 31, 2018 | $3.64M | – |
See a number that looks wrong?